Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

Drugs such as gemcitabine that increase replication stress are effective chemotherapeutics in a range of cancer settings. These drugs effectively block replication and promote DNA damage, triggering a cell cycle checkpoint response through the ATR–CHK1 pathway. Inhibiting this signalling pathway sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Oo, Zay Yar, Proctor, Martina, Stevenson, Alexander J., Nazareth, Deborah, Fernando, Madushan, Daignault, Sheena M., Lanagan, Catherine, Walpole, Sebastian, Bonazzi, Vanessa, Škalamera, Dubravka, Snell, Cameron, Haass, Nikolas K., Larsen, Jill E., Gabrielli, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599846/
https://www.ncbi.nlm.nih.gov/pubmed/31044505
http://dx.doi.org/10.1002/1878-0261.12497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599846/
https://www.ncbi.nlm.nih.gov/pubmed/31044505
http://dx.doi.org/10.1002/1878-0261.12497

Ejemplares similares